A new study published in PLOS Global Public Health shows that a short, all-oral, 6-month treatment regimen for drug-resistant #tuberculosis can save national governments up to US$740 million annually. This regimen will be included in the new World Health Organization (WHO) guidelines for the treatment of DR-TB, a form of the disease which impacts nearly half a million people each year. Find out more about how the cost of implementing this therapy is potentially 40-90% less expensive than current regimens: https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0001287 #EndTB